Kyle D. Kuvalanka
Overview
Kyle D. Kuvalanka received an average of $994K in total compensation, including $243K in salary, at Syros Pharmaceuticals between 2015 and 2016.
Source: SEC filing on April 25, 2017.
Related executives
We found seven more executives who work or worked at Syros Pharmaceuticals.
Nancy Simonian
Syros Pharmaceuticals
Chief Executive Officer
Eric Olson
Syros Pharmaceuticals
Chief Scientific Officer
David Roth
Syros Pharmaceuticals
Chief Medical Officer
Jason Haas
Syros Pharmaceuticals
Chief Financial Officer
Joseph Ferra
Syros Pharmaceuticals
Chief Financial Officer
Jeremy Springhorn
Syros Pharmaceuticals
Chief Business Officer
Gerald Quirk
Syros Pharmaceuticals